HILARY ANDERSON: Open Payments
NPI 1164076626 · ATASCADERO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,092 in 108 payments from 15 companies in 2025. Trend: 2023 $532 · 2024 $2,381 · 2025 $3,092
Food & beverage: $3,092
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $540 |
| GlaxoSmithKline, LLC. | 24 | $518 |
| Verona Pharma, Inc. | 11 | $339 |
| Amgen Inc. | 16 | $338 |
| Philips North America LLC | 12 | $263 |
| Regeneron Healthcare Solutions, Inc. | 7 | $236 |
| Electromed, Inc. | 9 | $184 |
| Insmed, Inc. | 7 | $142 |
| Madrigal Pharmaceuticals | 1 | $123 |
| Ascensia Diabetes Care Us Inc. | 2 | $111 |
Products named: TEZSPIRE, Ohtuvayre, Vest Therapy Und, TRELEGY ELLIPTA, DUPIXENT, SMARTVEST, FASENRA, BREZTRI.
Industry payments across CA — which companies pay providers there.
